Creekmur Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$464K Sell
8,359
-4,320
-34% -$253K 0.08% 132
2025
Q2
$875K Buy
12,679
+3,648
+40% +$248K 0.15% 101
2025
Q1
$627K Buy
9,031
+8,010
+785% +$662K 0.13% 88
2024
Q4
$87.8K Sell
1,021
-128
-11% -$13.8K 0.02% 165
2024
Q3
$137K Buy
1,149
+7
+0.6% +$934 0.03% 136
2024
Q2
$163K Buy
1,142
+225
+25% +$29.8K 0.04% 142
2024
Q1
$118K Buy
+917
New +$109K 0.04% 155

Other funds holding NVO

Creekmur Asset Management's NVO Position: Q3 2025 in Review

Creekmur Asset Management reduced its Novo Nordisk (NVO) stake by 34% in Q3 2025, selling an estimated $253K and leaving 8,359 shares worth $464K. The position accounts for 0.08% of the portfolio, ranked #132.

Creekmur Asset Management first reported a position in NVO in Q1 2024 and has held it in 7 quarters since. The position peaked at $875K in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Creekmur Asset Management held 8,359 shares of Novo Nordisk worth $464K as of Q3 2025.
  • Creekmur Asset Management sold 4,320 Novo Nordisk shares in Q3 2025, an estimated $253K.
  • Novo Nordisk made up 0.08% of Creekmur Asset Management's portfolio in Q3 2025, its #132 holding.
  • Creekmur Asset Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 7 quarters since.
  • Creekmur Asset Management's Novo Nordisk position peaked at $875K in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.